| Metric | Current Period | Prior Year Same Period | YoY |
|---|---|---|---|
| Revenue / Net Sales | ¥3526.5B | ¥3530.4B | -0.1% |
| Operating Income / Operating Profit | ¥480.8B | ¥492.0B | -2.3% |
| Ordinary Income | ¥512.8B | ¥521.5B | -1.7% |
| Net Income / Net Profit | ¥340.8B | ¥447.7B | -23.9% |
FY2026 results: Revenue ¥3526.5B (¥-3.9B YoY, -0.1%), Operating Income ¥480.8B (¥-11.2B YoY, -2.3%), Ordinary Income ¥512.8B (¥-8.7B YoY, -1.7%), Net Income ¥340.8B (¥-106.9B YoY, -23.9%). Top-line was flat while Operating Margin remained high at 13.6%, but Net Income declined sharply by -23.9%, indicating a notable deterioration in bottom-line quality. Operating margin decreased 30bp from 13.9% to 13.6%, and Net Margin plunged 302bp from 12.7% to 9.7%, suggesting that modest margin compression at the operating level was amplified at the net level by higher tax burden and one-off factors. EPS was ¥361.44 (prior year ¥461.95, -21.8%), ROE was 11.9% (down 5.4pt from 17.3%), indicating deterioration across profitability metrics. Meanwhile, Operating Cash Flow (OCF) was ¥471.6B (1.38x Net Income), and Free Cash Flow was ¥290.3B, demonstrating solid cash generation. Equity Ratio was 76.1% (up 3.7pt from 72.4%), showing an extremely strong balance sheet. Dividend was ¥110 (Payout Ratio 16.2%, FCF coverage 4.0x), indicating ample capacity for returns. Company guidance for the next fiscal year: Revenue ¥3,670B (+4.1%), Operating Income ¥508B (+5.7%), while Ordinary Income is projected ¥500B (-2.5%), reflecting a cautious stance. The core business earnings base is intact; resolving the transient deterioration in Net Income and reversing operating margin pressures will be the next period’s focus.
[Revenue] Revenue ¥3,526.5B was flat YoY (-0.1%, -¥3.9B). By segment: Synthetic Resin Molding Products Business ¥3,156.9B (prior ¥3,159.4B, -0.1%), Beds and Furniture Business ¥369.6B (prior ¥370.9B, -0.4%), with slight declines in both core resin and beds. Composition ratio was Synthetic Resin 89.5%, Beds 10.5%, unchanged from prior year. The core resin business remained stable supported by steady automotive-related demand, but customer production adjustments and delayed price pass-through likely weighed on performance. The Beds business declined slightly due to domestic market maturity. No explicit disclosure of FX impact, but if overseas sales exist, yen appreciation could have reduced reported revenue. Continued stagnation in top-line growth would pose a mid-term risk of reduced fixed-cost absorption, pressuring margins.
[Profitability] Operating Income ¥480.8B (YoY -2.3%, -¥11.2B); Operating Margin 13.6% (prior 13.9%, -30bp) remained high though modestly compressed. Segment profits: Synthetic Resin ¥476.6B (prior ¥490.2B, -2.8%), Beds ¥59.7B (prior ¥59.7B, flat), with the decrease driven by the core resin segment. Corporate expenses were ¥55.6B (prior ¥57.8B, -3.9%), slightly improved but not enough to offset business profit decline. Rising raw material and energy costs and SG&A front-loaded investments (R&D and personnel) likely pressured operating margins. Ordinary Income ¥512.8B (YoY -1.7%) moderated the operating decline due to non-operating income contributions. Net Income ¥340.8B (YoY -23.9%, -¥106.9B) shows a large divergence from Ordinary Income, strongly suggesting higher tax burden or one-off losses (extraordinary losses). Comprehensive Income ¥400.5B (prior ¥541.9B, -26.1%) also declined significantly; Other Comprehensive Income ¥59.7B (the difference from Net Income) likely reflects FX translation adjustments etc. In conclusion, while revenue and operating profit declined modestly, operating-level profitability is broadly maintained and the large drop in Net Income is mainly attributable to non-recurring factors.
The Synthetic Resin Molding Products Business posted Revenue ¥3,156.9B (YoY -0.1%) and Segment Profit ¥476.6B (YoY -2.8%), with a margin of 15.1% (prior 15.5%, -40bp). Automotive plastic components remained resilient, but customer production adjustments and higher raw material costs slightly compressed margins. Assets were ¥2,699.0B (prior ¥2,609.2B, +3.4%), indicating expansion of production capacity and higher working capital. Depreciation ¥105.8B (prior ¥110.7B), Capital Expenditure ¥177.9B (prior ¥188.1B), showing a somewhat restrained investment pace. The Beds and Furniture Business had Revenue ¥369.6B (YoY -0.4%), Segment Profit ¥59.7B (flat), and margin 16.2% (prior 16.1%, +10bp), a slight improvement. Domestic market maturity makes revenue expansion difficult, but cost control preserved margins. Assets ¥482.9B (prior ¥467.1B, +3.4%), Depreciation ¥18.4B (prior ¥18.7B), Capex ¥7.3B (prior ¥7.1B), indicating stable asset and investment trends. Declining margins in Synthetic Resin are pressuring company-wide operating margin; recovery in the core business margin through price pass-through and mix improvement is a key issue for next fiscal year.
[Profitability] Operating Margin 13.6%, down 30bp from 13.9% but still at a high level. ROE 11.9% (down 5.4pt from 17.3%) reflects the large drop in Net Income and sits near the lower bound of a favorable range (10–15%). ROA (on Ordinary Income basis) 13.3% (down 0.4pt from 13.7%) remains stable. [Cash Quality] OCF ¥471.6B is 1.38x Net Income ¥340.8B, indicating good cash backing for profits. Accrual ratio -3.3% (=(Net Income ¥340.8B - OCF ¥471.6B) ÷ Total Assets ¥3,935.9B) is negative, implying high earnings quality. [Investment Efficiency] Total Asset Turnover 0.90x (= Revenue ¥3,526.5B ÷ Total Assets ¥3,935.9B) slightly declined from 0.93x, indicating modest deterioration in asset efficiency. [Financial Soundness] Equity Ratio 76.1% (up 3.7pt from 72.4%) is extremely strong, with Financial Leverage 1.31x, reflecting a conservative capital structure. Cash and Cash Equivalents ¥1,416.6B represent 36.0% of Total Assets, providing a substantial liquidity cushion.
OCF ¥471.6B (prior ¥542.2B, -13.0%) exceeded Net Income ¥340.8B by ¥130.8B, supported by non-cash depreciation ¥125.7B (prior ¥130.1B) and disciplined working capital management, sustaining cash generation. OCF/Net Income ratio 1.38x indicates high earnings quality. Investing Cash Flow -¥181.3B (prior -¥238.9B) reflects growth investments centered on CapEx but was more restrained YoY. Free Cash Flow ¥290.3B (= OCF ¥471.6B + Investing CF -¥181.3B) was strongly positive, covering dividend payments ¥72.1B by 4.0x, supporting sustainability of returns. Financing Cash Flow -¥313.6B (prior -¥351.5B) likely driven by dividends and share repurchases, and Cash & Cash Equivalents at period-end were ¥1,416.6B (prior ¥1,410.9B, +¥5.6B), a slight increase. The YoY decline in OCF was driven by lower Net Income, but the structural basis for CF generation remains intact, suggesting OCF could recover if Net Income normalizes in subsequent periods.
Ordinary Income ¥512.8B vs Net Income ¥340.8B shows a bridge gap of ¥172.0B, implying significant tax burden or extraordinary losses. Prior year bridged Ordinary Income ¥521.5B → Net Income ¥447.7B had a gap of ¥73.8B, so the gap widened ¥98.2B this year. This points to likely non-recurring factors such as higher taxes, impairment losses, or restructuring charges. The difference between Comprehensive Income ¥400.5B and Net Income ¥340.8B (¥59.7B) is Other Comprehensive Income, likely impacted by FX translation adjustments or pension valuation differences. Disclosure of non-operating income composition is limited, but Ordinary Income exceeded Operating Income by ¥32.0B, suggesting contributions from interest/dividend income or equity method gains with relatively high quality. OCF ¥471.6B materially exceeds Net Income ¥340.8B, indicating low accruals and smooth cash realization, which supports high earnings quality. The modest 30bp decline in Operating Margin indicates core operating strength is maintained and deterioration at Net Income level is largely attributable to one-off factors. If tax burden or special losses abate next fiscal year, Net Margin could recover toward the Ordinary Income margin (around the mid-teens).
Company guidance (FY2027 Full Year): Revenue ¥3,670B (YoY +4.1%, +¥143.5B), Operating Income ¥508B (YoY +5.7%, +¥27.2B), Ordinary Income ¥500B (YoY -2.5%, -¥12.8B), Net Income ¥340B (flat YoY, -¥0.8B). The company expects revenue and operating income growth but is cautious on Ordinary and Net Income. Assumed Operating Margin 13.8% (vs current 13.6%, +20bp), expecting progress on price pass-through, mix improvement, and cost optimization. Progress rates versus full-year targets are: Revenue 96.1%, Operating Income 94.6%, Ordinary Income 102.6%, Net Income 100.2% — indicating slight shortfall at the operating level but outperformance in ordinary and net metrics to date. Additional ¥143.5B in revenue and ¥27.2B in operating income needed in H2; achievement depends on seasonality and order trends but is feasible. The Ordinary Income decline may assume a temporary reduction in non-operating income, and flat Net Income incorporates normalization of tax burden cautiously. EPS forecast ¥182.55 (current period ¥361.44 is roughly half) may reflect share count changes (share buybacks) or refer to a different period; consistency should be confirmed. Dividend guidance ¥56 (current ¥110) similarly may reflect period mismatch. No disclosure of backlog; revenue growth assumption likely rests on recovery in automotive demand for the Synthetic Resin business and new product launches in Beds business.
Annual dividend ¥110 (interim ¥40, year-end ¥70), a substantial increase from prior assumed annualized ¥70 (prior interim/assumed). Payout Ratio 16.2% (= Dividend Total ¥72.1B ÷ Net Income ¥340.8B ×100) is low, indicating room for further increases. Free Cash Flow ¥290.3B covers dividend payments ¥72.1B by 4.0x, supporting high sustainability. DOE (Dividend on Equity) 2.8% (= Dividend Total ¥72.1B ÷ Net Assets ¥2,995.7B ×100) is conservative given Equity Ratio 76.1% and Cash & Cash Equivalents ¥1,416.6B, suggesting scope for stronger returns. The company’s dividend guidance ¥56 may be a period mismatch; maintenance or increase from the ¥110 full-year base is the baseline expectation. Disclosure on share buybacks is limited, but part of Financing CF -¥313.6B may have funded buybacks, implying Total Return Ratio could exceed the Payout Ratio of 16.2%. Considering the transient deterioration in Net Income, adopting dividend policy metrics based on OCF or FCF could be key to maintaining stable returns.
Large Net Income decline (-23.9%) and recurrence risk of one-off factors: The ¥172.0B gap between Ordinary Income ¥512.8B and Net Income ¥340.8B widened by ¥98.2B from prior year’s ¥73.8B gap, suggesting taxes and extraordinary losses heavily pressured Net Income. Risks include higher effective tax rates, ongoing restructuring costs, or one-off impairments at overseas subsidiaries. If normalization is delayed, low Net Margin could persist. Recovery pace of Net Margin from current 9.7% (prior 12.7%) is critical to investor confidence.
Pressure on Operating Margin (-30bp) and fixed-cost absorption risk: Operating Margin 13.6% decreased from 13.9% amid flat revenue and higher raw material/energy costs and SG&A increases. The core Synthetic Resin margin dropped to 15.1% (prior 15.5%, -40bp); delayed price pass-through and customer price pressure could sustain margin erosion. Continued revenue growth of -0.1% would undermine fixed-cost absorption and could turn operating leverage negative.
Cyclicality of automotive-related demand and customer concentration risk: Synthetic Resin business (89.5% of sales) is centered on automotive plastic parts; production adjustments, model change cycles, and changes in component composition due to electrification directly affect orders and sales. High dependence on specific OEMs increases revenue vulnerability to customer downturns or procurement policy changes. FX fluctuations reducing overseas sales value and rising local production costs also warrant monitoring.
Profitability & Returns
| Metric | Company | Median (IQR) | Delta |
|---|---|---|---|
| Operating Margin | 13.6% | 7.8% (4.6%–12.3%) | +5.9pt |
Operating Margin 13.6% exceeds the industry median 7.8% by 5.9pt, placing Nifco among the higher profitability peers in manufacturing.
Growth & Capital Efficiency
| Metric | Company | Median (IQR) | Delta |
|---|---|---|---|
| Revenue Growth Rate (YoY) | -0.1% | 3.7% (-0.4%–9.3%) | -3.8pt |
Revenue growth -0.1% lags the industry median 3.7% by 3.8pt, indicating inferior growth performance and highlighting top-line expansion as a future challenge.
※ Source: Company compilation
Transient deterioration in Net Income and likelihood of normalization next fiscal year: While Ordinary Income fell only -1.7%, Net Income dropped -23.9% mainly due to tax burden and special losses. The fact that OCF ¥471.6B is 1.38x Net Income ¥340.8B indicates strong cash backing for earnings and preserved core business resilience. The company’s next-year plan showing flat Net Income can be interpreted as conservatively assuming one-off factors will abate; if tax burden normalizes, Net Margin could recover toward Ordinary Income margin (mid-teens). The pace of Net Income normalization will be a watershed for shareholder value assessment.
Mild decline in Operating Margin and progress on price pass-through and mix improvement: Operating Margin of 13.6% is down 30bp but remains substantially above the industry median. Compression in the Synthetic Resin margin to 15.1% (-40bp) likely reflects higher raw materials and front-loaded SG&A investments. The company’s target Operating Margin 13.8% (+20bp) assumes successful price pass-through and cost optimization; if realized, this would reverse the margin contraction trend. Given Revenue growth -0.1% trails industry median 3.7%, revenue expansion is necessary to restore fixed-cost absorption, with automotive demand recovery and new product launches being key drivers.
This report is an AI-generated earnings analysis document produced from XBRL financial statement data. It is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled by the Company based on public financial statements. Investment decisions are your own responsibility; consult a professional advisor as appropriate.